Intra-abdominal, crystal-storing histiocytosis due to clofazimine in a patient with lepromatous leprosy and concurrent carcinoma of the colon

Leprosy Review

Volumn 75, Issue 2, 2004, Pages 171-176

  Pais, Anthony V ^a   Pereira, Savio ^a   Garg, Isha ^a   Stephen, John ^a   Antony, Meryl ^a   Inchara, Y K ^a  

^a ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE;

ADULT; ANAMNESIS; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BURULI ULCER; CARCINOGENICITY; CASE REPORT; CLINICAL EXAMINATION; COLON ADENOCARCINOMA; COLOSTOMY; COMORBIDITY; CRYSTAL; DRUG INDICATION; FEMALE; FROZEN SECTION; HISTIOCYTOSIS; HUMAN; HUMAN TISSUE; INOPERABLE CANCER; LAPAROTOMY; LEPROMATOUS LEPROSY; LYMPH NODE; LYMPH NODE BIOPSY; MYCOBACTERIOSIS; MYCOBACTERIUM ULCERANS; OMENTUM; PERITONEUM; PIGMENTATION;

ABDOMINAL PAIN; ADENOCARCINOMA; ADULT; CLOFAZIMINE; COLONIC NEOPLASMS; CRYSTALLIZATION; FEMALE; HISTIOCYTOSIS; HUMANS; LEPROSTATIC AGENTS; LEPROSY, LEPROMATOUS;

EID: 4043116279     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Atkinson AJ Jr, Sheagren JN, Rubio JB, Knight V. Evaluation of B.663 in human leprosy. Int J Lepr, 1967; 35: 119-127.
2. Jagadeesan K, Visweswaran KK, Iyer KH. Acute abdomen in a patient treated with lamprene. Int Surg, 1975; 60: 208-209.
3. Desikan KV, Ramanujam D, Ramu G, Balakrishnan S. Autopsy findings in a case of lepromatous leprosy treated with clofazimine. Lepr Rev, 1975; 46: 181-189.
4. Karat ABA. Long-term follow-up of clofazimine (lamprene) in the management of reactive phases of leprosy. Lepr Rev, 1975;46: 105-109.
5. Jopling WH. Complications of treatment with clofazimine (lamprene: B663). Lepr Rev, 1976; 47: 1-3.
6. Harvey RF, Harman RRM, Black C et al. Abdominal pain and malabsorption due to tissue deposition of clofazimine (lamprene) crystals [Abstract]. Br J Dermatol 1977; 97: 19.
7. Mason GH, Ellis-Pegler RB, Arthur JF. CLofazimine and eosinophilic enteritis. Lepr Rev, 1977; 48: 175-180.
8. Bryceson A. Unnecessary laparotomy for abdominal pain and fever due to clofazimine. Lepr Rev, 1970; 50: 528-529.
9. McDougall AC, Horsfall WR, Hede JE, Chaplin AJ. Splenic infarction and tissue accumulation of crystals associated with the use of clofazimine (lamprene; B663) in the treatment of pyoderma gangrenosum. Br J Dermatol 1980; 102: 227-230.
10. de Bergeyck E, Janssens PG, de Muynck A. Radiological abnormalities of the ileum associated with the use of clofazimine (lamprene; B663) in the treatment of skin ulceration due to Mycobacterium ulcerans. Lepr Rev, 1980; 51: 221-228.
11. Belaube P, Devaux J, Pizzi M et al. small bowel deposition of crystals associated with the use of clofazimine (lamprene) in the treatment of prurigo nodularis. Int J Lepr, 1983; 51: 328-330.
12. Venencie PY, Cortez A, Orieux G et al. Clofazimine enteropathy. J Am Acad Dermatol, 1986; 15: 290-291.
13. Chong P-Y, Ti T-K. Severe abdominal pain in low dosage clofazimine. Pathology, 1993; 25: 24-26.
14. Sukpanichnant S, Hargrove NS, Kachintorn U et al. Clofazimine-induced crystal-storing histiocytosis producing chronic abdominal pain in a leprosy patient. Am J Surg Pathol, 2000; 24: 129-135.
15. Conalty ML, Barry VC, Jina A. The antileprosy agent B.663 (clofazimine) and the reticuloendothelial system. Int J Lepr, 1971; 39: 479-492.
16. McDougall AC. Electron microscopic studies of the antileprosy drug B663 (clofazimine; lamprene). Int J Lepr, 1974; 42: 1-12.
17. Kapadia SB, Enzinger FM, Heffner DK et al. Crystal-storing histiocytosis associated with lymphoplasmacytic neoplasms. Report of three cases mimicking adult rhabdomyoma. Am J Surg Pathol, 1993; 17: 461-467.